Seattle Genetics

206,99 USD -1,32 (-0,63%)
Bid 207,00 USD
Ask 210,00 USD

Premiumpartner

Firmenbeschreibung

Seagen Inc. (ehemals Seattle Genetics) ist ein US-amerikanisches Biotechnologieunternehmen, das Therapien zur Krebsbehandlung auf Basis monoklonaler Antikörper entwickelt. Die Medikamente ADCETRIS® und PADCEV® verwenden die branchenführende Antikörper-Wirkstoff-Konjugat-Technologie (ADC) des Unternehmens. ADCETRIS ist bei bestimmten CD30-exprimierenden Lymphomen zugelassen, und PADCEV hilft bei der Therapie gegen metastasierten Urothelkarzinome. TUKYSA®, ein niedermolekularer Tyrosinkinasehemmer, wird bei der Bekämpfung bestimmter Brustkrebsarten angewendet.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Freefloat (47.2%),Felix J. Baker, Ph.D. (25.6%),BlackRock, Inc. (7.3%),Capital International Investors (7%),The Vanguard Group (6.6%),Wellington Management Group LLP (6.3%)
sharesOutstanding: 183381000.0000
ceo: David R. Epstein
board: Felix J. Baker, Todd E. Simpson, Charles Romp, Jean I. Liu, Natasha Hernday, Roger D. Dansey, Vaughn B. Himes, Lee Heeson, Peggy Pinkston, Sherry Pudloski, Lu Chen, William Compton
supervisoryBoard: Alpna Seth, Daniel G. Welch, David W. Gryska, John A. Orwin, Nancy A. Simonian, Ted Love, Sandra M. Swain, David R. Epstein
countryID: 20
faceValue: 0.0010
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: USA
countryName: USA

Kontakt

name: Peggy Pinkston
phone: +1-425-527-4160
email: investors@seagen.com
irWebSite: https://investor.seagen.com/overview/default.aspx

Adresse

street: 21717-30th Drive S.E., Building 3
city: Bothell, WA 98021, USA
phone: +1-425-527-4000
webSite: https://www.seagen.com/
email: contact@seagen.com

Finanzen (kurz)

year: 2019 cash: 274.6000
balanceSheetTotal: 2205.9000 liabilities: 329.6000
shareCapital: 0.1720 totalShareholdersEquity: 1876.3000
sales: 916.7000 incomeBeforeTaxes: -158.7000
netIncome: -158.7000 cashFlow: 196.4000
employees: 1605 currencyID: 4
units: 1000000 currency: USD
year: 2020 cash: 558.4000
balanceSheetTotal: 4000.9000 liabilities: 512.8000
shareCapital: 0.1810 totalShareholdersEquity: 3488.1000
sales: 2175.5000 incomeBeforeTaxes: 615.7000
netIncome: 613.7000 cashFlow: 283.9000
employees: 2092 currencyID: 4
units: 1000000 currency: USD
year: 2021 cash: 424.8000
balanceSheetTotal: 3719.6000 liabilities: 654.5000
shareCapital: 0.1830 totalShareholdersEquity: 3065.1000
sales: 1574.4000 incomeBeforeTaxes: -675.7000
netIncome: -674.5000 cashFlow: -133.6000
employees: 2675 currencyID: 4
units: 1000000 currency: USD

Finanzen (kurz)

year: 2019
cash: 274.6000
balanceSheetTotal: 2205.9000
liabilities: 329.6000
shareCapital: 0.1720
totalShareholdersEquity: 1876.3000
sales: 916.7000
incomeBeforeTaxes: -158.7000
netIncome: -158.7000
cashFlow: 196.4000
employees: 1605
currencyID: 4
units: 1000000
currency: USD
year: 2020
cash: 558.4000
balanceSheetTotal: 4000.9000
liabilities: 512.8000
shareCapital: 0.1810
totalShareholdersEquity: 3488.1000
sales: 2175.5000
incomeBeforeTaxes: 615.7000
netIncome: 613.7000
cashFlow: 283.9000
employees: 2092
currencyID: 4
units: 1000000
currency: USD
year: 2021
cash: 424.8000
balanceSheetTotal: 3719.6000
liabilities: 654.5000
shareCapital: 0.1830
totalShareholdersEquity: 3065.1000
sales: 1574.4000
incomeBeforeTaxes: -675.7000
netIncome: -674.5000
cashFlow: -133.6000
employees: 2675
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2020 units: 1000000
balanceSheetTotal: 4000.9000 cash: 558.4000
currentAssets: 3062.4000 liabilities: 388.1000
totalLiabilitiesEquity: 4000.9000 totalShareholdersEquity: 3488.1000
employees: 2092 property: 196.7000
intangibleAssets: 0.0000 inventories: 116.1000
accountsReceivable: 325.0000 accountsPayable: 78.1000
liabilitiesTotal: 512.8000 commonStock: 0.1810
sales: 2175.5000 netIncome: 613.7000
operatingResult: 596.9000 investments: 827.1000
incomeTaxes: 2.0000 grossProfit: 2175.5000
revenuePerEmployee: 1039913.9579 cashFlow: 856.6000
cashFlowInvesting: -1419.0000 cashFlowFinancing: 846.1000
cashFlowTotal: 283.9000 accountingStandard: US GAAP
equityRatio: 87.1829 debtEquityRatio: 14.7014
liquidityI: 143.8804 liquidityII: 227.6217
netMargin: 28.2096 grossMargin: 100.0000
cashFlowMargin: 39.3749 ebitMargin: 27.4374
ebitdaMargin: 0.0000 preTaxROE: 17.6514
preTaxROA: 15.3890 roe: 17.5941
roa: 15.3390 revenuesGrowth: 137.3186
taxExpenseRate: 0.3248 equityTurnover: 0.6237
epsBasic: 3.5100 epsDiluted: 3.3700
shareCapital: 0.1810 incomeBeforeTaxes: 615.7000
priceEarningsRatioCompany: 52.3362 priceCashFlowRatio: 37.4936
dividendYield: 0.0000 bookValuePerShare: 19.9509
marketCap: 32117005800.0000 earningsYield: 1.9107
cashFlowPerShare: 4.8995 priceBookValueRatio: 9.2076
dividendsPerShare: 0.0000 priceEarningsRatio: 52.3334
netEarningsPerShare: 3.5102 currency: USD
year: 2021 units: 1000000
balanceSheetTotal: 3719.6000 cash: 424.8000
currentAssets: 2869.2000 liabilities: 568.9000
totalLiabilitiesEquity: 3719.6000 totalShareholdersEquity: 3065.1000
employees: 2675 property: 210.1000
intangibleAssets: 0.0000 inventories: 200.7000
accountsReceivable: 389.3000 accountsPayable: 114.8000
liabilitiesTotal: 654.5000 commonStock: 0.1830
sales: 1574.4000 netIncome: -674.5000
operatingResult: -682.1000 investments: 1228.7000
incomeTaxes: -1.2000 grossProfit: 1574.4000
revenuePerEmployee: 588560.7477 cashFlow: -499.0000
cashFlowInvesting: 288.9000 cashFlowFinancing: 77.8000
cashFlowTotal: -133.6000 accountingStandard: US GAAP
equityRatio: 82.4040 debtEquityRatio: 21.3533
liquidityI: 74.6704 liquidityII: 143.1007
netMargin: -42.8417 grossMargin: 100.0000
cashFlowMargin: -31.6946 ebitMargin: -43.3244
ebitdaMargin: 0.0000 preTaxROE: -22.0450
preTaxROA: -18.1659 roe: -22.0058
roa: -18.1337 netIncomeGrowth: -209.9071
revenuesGrowth: -27.6304 taxExpenseRate: 0.1776
equityTurnover: 0.5137 epsBasic: -3.7000
epsDiluted: -3.7000 epsBasicGrowth: -205.4131
shareCapital: 0.1830 incomeBeforeTaxes: -675.7000
priceCashFlowRatio: -56.4020 dividendYield: 0.0000
bookValuePerShare: 16.8368 marketCap: 28144620800.0000
earningsYield: -2.3933 cashFlowPerShare: -2.7410
priceBookValueRatio: 9.1823 dividendsPerShare: 0.0000
netEarningsPerShare: -3.7051 currency: USD
year: 2022 priceCashFlowRatio: -75.4714
dividendYield: 0.0000 bookValuePerShare: 16.8368
marketCap: 37660207863.6800 earningsYield: -1.7886
pegRatio: 0.2722 cashFlowPerShare: -2.7410
netAssetsPerShare: 16.8368 priceBookValueRatio: 12.2868
netEarningsPerShare: -3.7051 currency: USD

Finanzen (ausführlich)

year: 2020
units: 1000000
balanceSheetTotal: 4000.9000
cash: 558.4000
currentAssets: 3062.4000
liabilities: 388.1000
totalLiabilitiesEquity: 4000.9000
totalShareholdersEquity: 3488.1000
employees: 2092
property: 196.7000
intangibleAssets: 0.0000
inventories: 116.1000
accountsReceivable: 325.0000
accountsPayable: 78.1000
liabilitiesTotal: 512.8000
commonStock: 0.1810
sales: 2175.5000
netIncome: 613.7000
operatingResult: 596.9000
investments: 827.1000
incomeTaxes: 2.0000
grossProfit: 2175.5000
revenuePerEmployee: 1039913.9579
cashFlow: 856.6000
cashFlowInvesting: -1419.0000
cashFlowFinancing: 846.1000
cashFlowTotal: 283.9000
accountingStandard: US GAAP
equityRatio: 87.1829
debtEquityRatio: 14.7014
liquidityI: 143.8804
liquidityII: 227.6217
netMargin: 28.2096
grossMargin: 100.0000
cashFlowMargin: 39.3749
ebitMargin: 27.4374
ebitdaMargin: 0.0000
preTaxROE: 17.6514
preTaxROA: 15.3890
roe: 17.5941
roa: 15.3390
revenuesGrowth: 137.3186
taxExpenseRate: 0.3248
equityTurnover: 0.6237
epsBasic: 3.5100
epsDiluted: 3.3700
shareCapital: 0.1810
incomeBeforeTaxes: 615.7000
priceEarningsRatioCompany: 52.3362
priceCashFlowRatio: 37.4936
dividendYield: 0.0000
bookValuePerShare: 19.9509
marketCap: 32117005800.0000
earningsYield: 1.9107
cashFlowPerShare: 4.8995
priceBookValueRatio: 9.2076
dividendsPerShare: 0.0000
priceEarningsRatio: 52.3334
netEarningsPerShare: 3.5102
currency: USD
year: 2021
units: 1000000
balanceSheetTotal: 3719.6000
cash: 424.8000
currentAssets: 2869.2000
liabilities: 568.9000
totalLiabilitiesEquity: 3719.6000
totalShareholdersEquity: 3065.1000
employees: 2675
property: 210.1000
intangibleAssets: 0.0000
inventories: 200.7000
accountsReceivable: 389.3000
accountsPayable: 114.8000
liabilitiesTotal: 654.5000
commonStock: 0.1830
sales: 1574.4000
netIncome: -674.5000
operatingResult: -682.1000
investments: 1228.7000
incomeTaxes: -1.2000
grossProfit: 1574.4000
revenuePerEmployee: 588560.7477
cashFlow: -499.0000
cashFlowInvesting: 288.9000
cashFlowFinancing: 77.8000
cashFlowTotal: -133.6000
accountingStandard: US GAAP
equityRatio: 82.4040
debtEquityRatio: 21.3533
liquidityI: 74.6704
liquidityII: 143.1007
netMargin: -42.8417
grossMargin: 100.0000
cashFlowMargin: -31.6946
ebitMargin: -43.3244
ebitdaMargin: 0.0000
preTaxROE: -22.0450
preTaxROA: -18.1659
roe: -22.0058
roa: -18.1337
netIncomeGrowth: -209.9071
revenuesGrowth: -27.6304
taxExpenseRate: 0.1776
equityTurnover: 0.5137
epsBasic: -3.7000
epsDiluted: -3.7000
epsBasicGrowth: -205.4131
shareCapital: 0.1830
incomeBeforeTaxes: -675.7000
priceCashFlowRatio: -56.4020
dividendYield: 0.0000
bookValuePerShare: 16.8368
marketCap: 28144620800.0000
earningsYield: -2.3933
cashFlowPerShare: -2.7410
priceBookValueRatio: 9.1823
dividendsPerShare: 0.0000
netEarningsPerShare: -3.7051
currency: USD
year: 2022
priceCashFlowRatio: -75.4714
dividendYield: 0.0000
bookValuePerShare: 16.8368
marketCap: 37660207863.6800
earningsYield: -1.7886
pegRatio: 0.2722
cashFlowPerShare: -2.7410
netAssetsPerShare: 16.8368
priceBookValueRatio: 12.2868
netEarningsPerShare: -3.7051
currency: USD